744 related articles for article (PubMed ID: 19305368)
1. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
2. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
3. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
4. Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
[No Abstract] [Full Text] [Related]
5. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
6. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
7. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
Mott TF; Leach L; Johnson L
J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
[No Abstract] [Full Text] [Related]
8. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
9. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
Lewis H; Lewis J
Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
[TBL] [Abstract][Full Text] [Related]
12. Transdermal methylphenidate system: old wine in a new bottle.
Bukstein OG
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
[TBL] [Abstract][Full Text] [Related]
13. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
14. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
15. Dexmethylphenidate (Focalin) for ADHD.
Med Lett Drugs Ther; 2002 May; 44(1130):45-6. PubMed ID: 12011757
[No Abstract] [Full Text] [Related]
16. A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).
Weiss M; Wasdell M; Patin J
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1415-21. PubMed ID: 15502601
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
[No Abstract] [Full Text] [Related]
18. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.
Goetz M; Surman CB; Mlynarova E; Krsek P
J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167
[No Abstract] [Full Text] [Related]
19. Pharmacological management of treatment-induced insomnia in ADHD.
Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
[No Abstract] [Full Text] [Related]
20. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
Le Heuzey MF; Vergnaud S; Mouren MC
Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
